• Reduce the risk and costs of conducting due diligence at various facilities in China
• The collaborative nature of this project enables biopharmaceutical decision-makers to engage in pre-competitive learning through the sharing of experiences and insights
• Reduce the risk and costs of conducting due diligence at various facilities in China via a shared-cost and time-efficient means to learn how, where, whether, and with whom to conduct biomarker and translational research in China
• Make more confident, better-informed decisions about leveraging the biomarker and translational research capabilities of China by providing a robust and quantitative assessment of the regions’ leading research service providers in a wide range of functional capabilities.
• Gain a robust understanding of the current state and utilization of biomarker and translational research capabilities in China
• Research is client-driven, through client participation in a project steering-committee, to ensure the project focuses precisely on clients’ strategic biomarker and translational research information needs
• The potential for longer term cost-savings in biomarker and translational research activities by leveraging comparatively low-cost expertise in emerging regions, while simultaneously reducing the risk of uncertainty as to the quality, competence, and reliability of service providers within these regions

  Download full Project Description                                         Contact Us           

Previous Page    Back to Project Description    Next Page